Johnson & Johnson (NYSE: JNJ) reduced its full-year sales and adjusted earnings guidance on Tuesday. IBM (NYSE: IBM) lowered its free cash flow outlook for 2022 on Monday. Citi cut its price target for Microsoft (NASDAQ: MSFT) this week as well. 

Those might seem like totally unrelated events. However, the bad news for all three of these giant companies is due to the same underlying factor. This chart shows a big problem for Johnson & Johnson, IBM, and Microsoft.

Continue reading

Source Fool.com